Live Webinar ADEPT ACS – Advances in Dyslipidaemia managEment and Practical sTrategies in ACS patients | 1 Sept 2022

Live Webinar

ADEPT ACS

Advances in Dyslipidaemia managEment and Practical sTrategies in ACS patients

1^st September 2022 (Thursday)

5:00 PM - 6:40 PM

6:00 PM - 7:40 PM

This program is endorsed by

IMPORTANT INSTRUCTION: For easy access and better experience, please join the Webinar room (Adobe Connect) in the web-browser only from your Mobile phone/Tablet/Desktop/Laptop.

Important Guide for Webinar Attendees

Please download & install the free Webinar Platform app (Adobe Connect) from the link below to join the live webinar session.

Download links of Adobe Connect Application (as applicable to your device):
PC - Windows | Mac

Quick Start Guide:

Desktop/Laptop Users
Mobile/Tablet Users

If you are joining from mobile phone, please choose "Join via Browser" option for easy and better experience.

Test your device & connection: Prior to attending the webinar session, please test your connection and device from this link and ensure all steps get the check/right (✔) mark. Follow the on-page guides at the diagnostic page.

FACULTY OF THE PROGRAM

Moderator

Prof. Juan-Carlos Kaski

DSc, MD (Hons), FRCP, FESC, FACC, FAHA, FRSM
Professor of Cardiovascular Science (Emeritus), St George’s, University of London

Prof. Juan-Carlos Kaski / DSc, MD (Hons), FRCP, FESC, FACC, FAHA, FRSM Professor of Cardiovascular Science (Emeritus), St George’s, University of London

Professor Juan-Carlos Kaski is an honorary consultant cardiologist at our diagnosticsand outpatient facility at 77 Wimpole Street, where he treats private patients.

He is Editor-in-Chief of European Cardiology Review Journal, Deputy Editor (IHD) of European Heart Journal and a member of the editorial board of over twenty major scientific journals, including the European Journal of Cardiology and the Journal of the American College of Cardiology, as well as immediate past associate editor of Cardiovascular Drugs and Therapy.

Prof Kaski is Doctor Honoris Causa of the University of St Luis in Argentina and the University Carol Davila, Bucharest. He has received numerous scientific and educational awards, including the Gold Medal of the Spanish Society of Cardiology, Scientiae Magistri Award (Rome), RAICES award (Argentina) and Fukushima University award (Japan), for his contribution to cardiovascular research and teaching.

Professor Kaski is Chairman-Elect of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the immediate past President and Chair of the Executive Board of the International Society of Pharmacotherapy, an affiliate member of the World Heart Federation.

Speakers

Prof Heinz Drexel

Head of the Department of Internal Medicine & Intensive Care, County Hospital Bregenz, Austria, CEO and Scientific Programme Director, VIVIT Institute, Feldkirch, Austria, Past-Dean of the Medical and Scientific Faculty at Private University of the Principality of Liechtenstein

Prof Heinz Drexel / Head of the Department of Internal Medicine & Intensive Care, County Hospital Bregenz, Austria, CEO and Scientific Programme Director, VIVIT Institute, Feldkirch, Austria, Past-Dean of the Medical and Scientific Faculty at Private University of the Principality of Liechtenstein.

Prof Drexel studied medicine at the University of Innsbruck and graduated with exceptional honours. He did his specialist training at the University Clinic for Internal Medicine in Innsbruck followed by additional specialist trainings in cardiology, endocrinology, metabolic disease, and angiology. Since then, he has lectured at the University of Innsbruck, and at the University Hospital of Zurich, amongst others. He has also visited the US for several research stays at the St. Elisabeth Medical Centre at Tufts University in Boston, MA.

In 1994, Prof Drexel became Head of the Department for Internal Medicine at the State Hospital Feldkirch (LKHF) and he then founded the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), headquartered at the LKHF, and has been its CEO since its origin. Since 2020 he is head of the Department of Internal Medicine & Intensive Care at the County Hospital Bregenz. A large number of publications in the world’s leading medical journals and extensive reviewer functions for the journals Diabetes Care, Diabetologia, European Heart Journal, etc. are testimony of his intensive publishing activities and his scientific excellence, and he is also a member of national and international advisory boards.

His scientific focus areas are cardiovascular disease, diabetes, metabolism, cholesterol and pain research. He fulfils his teaching assignment for internal medicine at the LKHF, which is an academic teaching hospital of the Medical University of Innsbruck, by regularly giving lectures about internal medicine and pharmacology.

Prof Drexel is an active member of the scientific committee of the Federal State of Vorarlberg, and titles of honour such as the Fellowship of the European Society of Cardiology (FESC), the Fellowship of the American Heart Association (FAHA) and the Fellowship of the Royal College of Physicians Edinburgh (FRCP Ed.) are amongst his accolades. During 2018-2020 he was the President of the ESC- Working Group in Cardiovascular Pharmacotherapy.

Prof Philippe Gabriel Steg

Professor of Cardiology at University Paris, France and at the National Heart and Lung Institute, Imperial College, London, UK

Prof Philippe Gabriel Steg / Professor of Cardiology at University Paris, France and at the National Heart and Lung Institute, Imperial College, London, UK.

Prof Steg has been a Professor of Cardiology at University Paris - Diderot since 1994. He is also Professor at the National Heart and Lung Institute, Imperial College, London, UK. He works as an interventional cardiologist and is Director of the Coronary Care Unit of Hôpital Bichat, in Paris, France. He is also Director of the “Clinical Research in Atherothrombosis” Research Team, which belongs to INSERM U-1148, Paris and a Co-Coordinator of the Département Hospitalo-Universitaire FIRE (Fibrosis, Inflammation and REmodeling) affiliated
with INSERM, Université Paris-Diderot and Assistance Publique – Hôpitaux de Paris. He is chair of the FACT (French Alliance for Cardiovascular Clinical Trials) academic research network.

Prof Steg’s research interests are in the field of coronary artery disease. He is a former member of the Board of the French Society of Cardiology, an honorary member of the Institut Universitaire de France, and received the silver medal of the European Society of Cardiology in 2011.

Prof Steg led the TAO and EUROMAX trials and is currently chairing or co-chairing several trials or registries, such as ODYSSEY-CV Outcomes, CLARIFY, THEMIS. He has authored more than 650 articles in peer-reviewed international journals. He is a member of the editorial boards for Circulation, Circulation: Cardiovascular Interventions, the European Heart Journal, and the European Heart Journal – Cardiovascular Pharmacotherapy. He is deputy
editor for the Journal of the American College of Cardiology. Finally, Prof Steg was Co-Chair of the task force in charge of the 2012 ESC Guidelines for management of ST-segment elevation myocardial.

AGENDA

1^st September 2022

- Welcome and Introduction
  Prof. Juan-Carlos Kaski

- Practical strategies for the management of dyslipidaemia – New targets
  Prof Heinz Drexel

- Optimising management of dyslipidaemia in ACS patients – Practical pathways
  Prof. Philippe Gabriel Steg
  
  Panel Discussion
  All Speakers

Closing Remarks
Prof. Juan-Carlos Kaski

Save your spot right now

Days

Hours

Minutes

Seconds